Lennox-Gastaut Syndrome: Perspective of a Parent and a Physician

Heather R McKee1, Barbara Glasgow2

  • 1Department of Neurology, Epilepsy Division, University of Cincinnati Gardner Neuroscience Institute, Cincinnati, OH, USA. heather.mckee@uc.edu.

Neurology and Therapy
|October 28, 2020
PubMed

Insights

This article offers a dual perspective on Lennox-Gastaut syndrome (LGS), detailing a parent's journey and an epileptologist's treatment experience with this severe epilepsy disorder.

Area of Science:

  • Neurology
  • Pediatric Epilepsy
  • Patient Advocacy

Background:

  • Lennox-Gastaut syndrome (LGS) is a rare and severe form of epilepsy that typically begins in childhood.
  • LGS is characterized by multiple seizure types, intellectual disability, and behavioral issues.
  • Managing LGS presents significant challenges for patients, families, and healthcare providers.

Purpose of the Study:

  • To provide a comprehensive overview of the lived experience of a parent caring for an individual with LGS.
  • To offer insights into the clinical management and treatment strategies employed by an epileptologist for LGS.
  • To highlight the collaborative relationship between caregivers and medical professionals in managing LGS.

Main Methods:

  • Qualitative narrative approach combining a parent's personal account and an epileptologist's clinical perspective.
  • Case study focusing on a 32-year-old male patient with LGS.
  • Ethical considerations including informed consent for publication.

Main Results:

  • The parent's narrative details the emotional, practical, and daily challenges of LGS from diagnosis onward.
  • The epileptologist's perspective outlines diagnostic criteria, treatment options, and the complexities of managing LGS.
  • The article underscores the importance of a multidisciplinary approach and strong patient-family support.

Conclusions:

  • LGS requires a lifelong, multifaceted management approach.
  • The patient and caregiver experience is central to understanding and improving LGS care.
  • Effective LGS management necessitates close collaboration between families and epilepsy specialists.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
132
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
101
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
179
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.9K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
124